All staff and students are invited to Heide Fettke's PhD confirmation.20 March, 11am, Seminar room 3, TRF level 2
Synopsis: The
last several years has seen the approval of multiple new therapies for advanced
prostate cancer that target the androgen receptor (AR) axis. Despite
improvements in clinical outcomes, resistance to these agents is inevitable.
This project aims to design and implement a highly sensitive next-generation
sequencing assay capable of identifying prostate-cancer associated mutations in
patient circulating tumour DNA (ctDNA) in order to understand therapeutic
response and resistance.
Supervisors: A/Prof Arun Azad, Prof Melissa Southey
No comments:
Post a Comment